LINC02261: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC02261

NCBI ID: G101929199

LINC02261

Other Name(s): long intergenic non-protein coding RNA 2261 | Long intergenic non-protein coding RNA 2261

LINC02261: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC02261 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA sequencing (RNA-seq) data. It is located between the genes HOMZ0029 and ZNF2 on chromosome 6 and has a length of approximately 292 nucleotides. LINC02261 is a non-coding RNA that is not translated into protein, but it is expressed in RNA-seq experiments and has been shown to be involved in various cellular processes such as cell adhesion, migration, and transcriptional regulation.

Drug Target Potential

The potential drug targets for LINC02261 are numerous and varied. One of the primary drug targets for LINC02261 is the regulation of cell adhesion. LINC02261 has been shown to be involved in the regulation of tight junction formation and cell-cell adhesion, which are critical processes for maintaining tissue structure and function. Additionally, LINC02261 has also been shown to be involved in the regulation of cell migration, which is a critical process for the development and maintenance of tissues and organs.

Another potential drug target for LINC02261 is its role in transcriptional regulation. LINC02261 has been shown to be involved in the regulation of gene expression, by either activating or repressing the expression of specific genes. This suggests that LINC02261 may be a useful biomarker for assessing the effectiveness of drugs that target gene expression.

Biomarker Potential

LINC02261 has the potential to serve as a biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. One of the primary reasons for its potential as a biomarker is its stability and expression in various tissues and cells, which allows it to be easily detected and measured. Additionally, LINC02261 has been shown to be expressed in a variety of tissues and cells, including neurons, glial cells, and immune cells, which suggests that it may be a useful biomarker for a range of diseases.

Another potential use for LINC02261 as a biomarker is its potential to serve as a therapeutic target. By targeting LINC02261, researchers may be able to improve the efficacy of drugs that are currently being used to treat certain diseases. Additionally, LINC02261 may also be a useful biomarker for tracking the effectiveness of new drugs in preclinical studies.

Conclusion

In conclusion, LINC02261 is a long intergenic non-protein-coding RNA that has been identified using RNA-seq data. It is involved in various cellular processes, including cell adhesion, migration, and transcriptional regulation, and has the potential to serve as a drug target and biomarker. Further research is needed to fully understand the role of LINC02261 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2261

The "LINC02261 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02261 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets